Monoclonal antibody: Rat anti-murine Chemokine Receptor 9 (Cdw199)

Scientists at the Georg-August-University produced a monoclonal antibody which recognises murine CD199, which is commonly known as chemokine receptor 9 (CCR9). The protein CCR9 is a member of the beta chemokine receptor family. It is a seven transmembrane protein similar to G protein coupled receptors. Chemokines and their receptors are key regulators of the thymocytes migration and maturation in normal and inflammation conditions. The specific ligand of this receptor is CCL25. It has been found that this receptor is differentially expressed by T-lymphocytes of small intestine and colon, suggested a role in the thymocytes recruitement and development that they may permit functional specialization of immune responses in different segment of the gastrointestinal tract, where they are not in other tissues. When tested against 10 different viral strains, CCR9 acted as a co-receptor for only one a single primary T-cell-tropic strain, HIV-1(UG-21). This lack of activity is interesting, given that CCR9 expresses a tyrosine rich amino-terminal element, reminiscent of CCR5, that has been postulated to be important for HIV co-receptor function.

Further Information: PDF

MBM ScienceBridge GmbH
Phone: (0551) 30724-151

Contact
Dr. Jens-Peter Horst

Media Contact

info@technologieallianz.de TechnologieAllianz e.V.

All latest news from the category: Technology Offerings

Back to home

Comments (0)

Write a comment

Newest articles

Making diamonds at ambient pressure

Scientists develop novel liquid metal alloy system to synthesize diamond under moderate conditions. Did you know that 99% of synthetic diamonds are currently produced using high-pressure and high-temperature (HPHT) methods?[2]…

Eruption of mega-magnetic star lights up nearby galaxy

Thanks to ESA satellites, an international team including UNIGE researchers has detected a giant eruption coming from a magnetar, an extremely magnetic neutron star. While ESA’s satellite INTEGRAL was observing…

Solving the riddle of the sphingolipids in coronary artery disease

Weill Cornell Medicine investigators have uncovered a way to unleash in blood vessels the protective effects of a type of fat-related molecule known as a sphingolipid, suggesting a promising new…

Partners & Sponsors